Hepatorenal syndrome (HRS), the extreme manifestation of renal impairment in patients with
cirrhosis, is characterized by reduction in renal blood flow and glomerular filtration rate …

Renal dysfunction is a common, life-threatening complication occurring in patients with liver
disease. Hepatorenal syndrome (HRS) has been defined as a purely “functional” type of …

Background The vasoconstrictor terlipressin is used for type 1 hepatorenal syndrome (HRS-
1) in many parts of the world and is part of the clinical practice guidelines in Europe …

The natural history of cirrhosis is characterised by an asymptomatic compensated phase
followed by a decompensated phase, marked by the development of overt clinical signs, the …

Sepsis and septic shock are characterized by life-threatening organ dysfunction caused by a
dysregulated host response to infection. The liver has a central role during sepsis, and is …

Acute renal failure (ARF) is a common complication in patients with decompensated
cirrhosis. The traditional diagnostic criteria of renal failure in these patients were proposed in …

Human serum albumin (HSA) is one of the most frequent treatments in patients with
decompensated cirrhosis. Prevention of paracentesis-induced circulatory dysfunction …

Background & Aims Hepatorenal syndrome type 1 (HRS-1) in patients with cirrhosis and
ascites is a functional, potentially reversible, form of acute kidney injury characterized by …

Description The purpose of this American Gastroenterological Association (AGA) Institute
Clinical Practice Update is to review the available published evidence and expert advice …

Hepatorenal syndrome (HRS), a serious complication of cirrhosis, is associated with high
mortality without treatment. Terlipressin with albumin is effective in the reversal of HRS …